IMC Chicago’s VanEck Pharmaceutical ETF PPH Stock Holding History

IMC Chicago’s Portfolio PPH Stock Details PPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$338K	Sell	3,257 -13,292	-80%	-$1.42M	﹤0.01%	4455
2025 Q4	$1.71M	Buy	+16,549	New	+$1.61M	﹤0.01%	2553
2025 Q2	–	Sell	-12,204	Closed	-$1.11M	–	3523
2025 Q1	$1.11M	Buy	12,204 +1,821	+18%	+$164K	﹤0.01%	2207
2024 Q4	$896K	Buy	+10,383	New	+$939K	﹤0.01%	2428
2024 Q2	–	Sell	-20,854	Closed	-$1.89M	–	2751
2024 Q1	$1.89M	Buy	+20,854	New	+$1.83M	﹤0.01%	1394
2023 Q1	–	Sell	-23,245	Closed	-$1.81M	–	1350
2022 Q4	$1.81M	Sell	23,245 -1,325	-5%	-$97.7K	﹤0.01%	843
2022 Q3	$1.65M	Sell	24,570 -2,804	-10%	-$207K	﹤0.01%	795
2022 Q2	$2.1M	Buy	27,374 +2,027	+8%	+$158K	﹤0.01%	686
2022 Q1	$2.02M	Buy	25,347 +920	+4%	+$70.4K	﹤0.01%	770
2021 Q4	$1.88M	Buy	+24,427	New	+$1.82M	﹤0.01%	840
2020 Q4	–	Sell	-21,667	Closed	-$1.35M	–	1093
2020 Q3	$1.35M	Buy	+21,667	New	+$1.37M	﹤0.01%	662

Other funds holding PPH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

BCIM

British Columbia Investment Management Victoria, British Columbia, Canada $17B AUM 31.69% 1-Year Est. Return

ERSOT

Employees Retirement System of Texas Austin, Texas $11.4B AUM 21.6% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

JSAM

J. Safra Asset Management New York $1.86B AUM 22.95% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Avalon Trust Santa Fe, New Mexico $1.45B AUM 35.31% 1-Year Est. Return

IMC Chicago's PPH Position: Q1 2026 in Review

IMC Chicago reduced its VanEck Pharmaceutical ETF (PPH) stake by 80% in Q1 2026, selling an estimated $1.42M and leaving 3,257 shares worth $338K. The position accounts for ﹤0.01% of the portfolio, ranked #4455.

IMC Chicago first reported a position in PPH in Q3 2020 and has held it in 11 quarters since. The position peaked at $2.1M in Q2 2022. 147 funds tracked by Wall St. Rank hold PPH as of Q1 2026.

IMC Chicago held 3,257 shares of VanEck Pharmaceutical ETF worth $338K as of Q1 2026.
IMC Chicago sold 13,292 VanEck Pharmaceutical ETF shares in Q1 2026, an estimated $1.42M.
VanEck Pharmaceutical ETF made up ﹤0.01% of IMC Chicago's portfolio in Q1 2026, its #4455 holding.
IMC Chicago first reported a position in VanEck Pharmaceutical ETF in Q3 2020 and has held it in 11 quarters since.
IMC Chicago's VanEck Pharmaceutical ETF position peaked at $2.1M in Q2 2022.
147 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q1 2026.

Based on IMC Chicago's 13F filing for Q1 2026, filed 5 May 2026.